These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32881614)

  • 1. Exercise-based cardiac rehabilitation for adults with implantable cardioverter defibrillators.
    Porritt K
    Br J Community Nurs; 2020 Sep; 25(9):460-461. PubMed ID: 32881614
    [No Abstract]   [Full Text] [Related]  

  • 2. Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator.
    Nielsen KM; Zwisler AD; Taylor RS; Svendsen JH; Lindschou J; Anderson L; Jakobsen JC; Berg SK
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD011828. PubMed ID: 30746679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the scope of practice for cardiac rehabilitation: managing patients with implantable cardioverter defibrillators.
    Sears SF; Kovacs AH; Conti JB; Handberg E
    J Cardiopulm Rehabil; 2004; 24(4):209-15. PubMed ID: 15286525
    [No Abstract]   [Full Text] [Related]  

  • 5. Rehabilitation of patients with implantable cardioverter/defibrillator: a literature review.
    Hussein NA; Thomas MA
    Acta Cardiol; 2008 Apr; 63(2):249-57. PubMed ID: 18468207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death is underestimated].
    Disertori M
    G Ital Cardiol (Rome); 2011 May; 12(5):374-8; discussion 378. PubMed ID: 21593957
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac rehabilitation in patients with pacemakers and implantable cardioverter defibrillators.
    Iliou MC; Blanchard JC; Lamar-Tanguy A; Cristofini P; Ledru F
    Monaldi Arch Chest Dis; 2016 Oct; 86(1-2):756. PubMed ID: 27748467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use].
    Francia P; Cappato R
    G Ital Cardiol (Rome); 2011 May; 12(5):379-82; discussion 382. PubMed ID: 21593958
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    McComb JM; Camm AJ
    BMJ; 2002 Nov; 325(7372):1050-1. PubMed ID: 12424150
    [No Abstract]   [Full Text] [Related]  

  • 10. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death].
    Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE
    Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Raj SR; Mitchell LB; Sheldon RS
    N Engl J Med; 2000 Jul; 343(1):68-9. PubMed ID: 10896549
    [No Abstract]   [Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillators.
    Pinski SL; Fahy GJ
    Am J Med; 1999 Apr; 106(4):446-58. PubMed ID: 10225249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillators: expanding indications.
    Naccarelli GV
    Curr Opin Cardiol; 2004 Jul; 19(4):317-22. PubMed ID: 15218389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identity of the cardiological rehabilitation with patients with implanted cardioverter-defibrillator].
    Pajak J; Jarosiński G; Nowak-Majda P; Walusiak M; Plewa M; Durmała J; Kargul W
    Wiad Lek; 2009; 62(1):26-9. PubMed ID: 19817254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardiac defibrillators and cardiac resynchronization therapy for heart failure in older adults.
    Goldfinger JZ; Choi AD; Adler ED
    Geriatrics; 2009 Aug; 64(8):20-9. PubMed ID: 20722313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable Cardioverter-Defibrillators in Trials of Drug Therapy for Heart Failure: A Systematic Review and Meta-Analysis.
    Gama F; Ferreira J; Carmo J; Costa FM; Carvalho S; Carmo P; Cavaco D; Morgado FB; Adragão P; Mendes M
    J Am Heart Assoc; 2020 Apr; 9(8):e015177. PubMed ID: 32290732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining?
    Spartalis M; Iliopoulos DC; Spartalis E; Athanasiou A; Paschou SA; Voudris V; Siasos G
    J Cardiol; 2020 May; 75(5):583-584. PubMed ID: 32115329
    [No Abstract]   [Full Text] [Related]  

  • 18. Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?
    Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton AE; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders GD
    Int J Cardiol; 2014 Mar; 172(1):253-4. PubMed ID: 24467982
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Josephson ME; Callans DJ; Buxton AE
    Ann Intern Med; 2000 Dec; 133(11):901-10. PubMed ID: 11103061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress on cardiac rehabilitation in patients with implanted cardiac defibrillator].
    Liu J; Li X; Xie W
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Aug; 37(4):736-740. PubMed ID: 32840093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.